Pharmaceutical

Brii Biosciences and Joincare sign licence agreement for BRII-693

Brii Biosciences and Joincare Pharmaceutical have signed a licence and technology transfer agreement for BRII-693 for MDR/XDR infections.

Jul 5, 2025 - 06:00
Brii Biosciences and Joincare sign licence agreement for BRII-693
Brii Biosciences and Joincare Pharmaceutical have signed a licence and technology transfer agreement for BRII-693 for MDR/XDR infections.
Read the original article

Tags:

Previous Article

Biocon’s Denosumab biosimilars gain EU marketing authorisation

Next Article

Theratechnologies shares surge 25% amid $254m Future Pak takeover

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

EC grants approval to Pfizer for $43bn Seagen acquisition 

EC grants approval to Pfizer for $43bn Seagen acquisition 

Oct 21, 2023

STAT+: Pharmalittle: Woodcock to retire from the FDA; Acrotech urged to speed up confirmatory study of cancer drugs

STAT+: Pharmalittle: Woodcock to retire from the FDA; A...

Nov 17, 2023

UK’s NICE recommends Pfizer’s rimegepant to treat migraine

UK’s NICE recommends Pfizer’s rimegepant to treat migraine

Jun 1, 2023